Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS1425 with Anthracycline-based Regimen in Neoadjuvant Breast Cancer
NCT01433562Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing DLBS1425 + Chemotherapy with Placebo + Chemotherapy (2 arms). Primary endpoint: Clinical response as measured by RECIST. Started Aug 2011; status: completed.
02
Drugs
DLBS1425
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01433562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433562.